Let's talk medical research

We’re thrilled to share that our CEO, Laurent Schockmel, has been named a top 40 Healthcare Transformer by Medical Marketing & Media (MM&M). This honor is given to visionaries driving innovation at the intersection of healthcare and technology, and it’s exciting to see Laurent in such great company. Laurent took the helm as CEO of Antidote in 2018 with the objective of harnessing our ...

Antidote recently conducted a survey with SCORR Marketing through which we asked nearly 4,000 patients about their perspectives on clinical trials. One key finding: patients with different conditions have different opinions on taking part in medical research. For example, in the survey, people with melanoma were joining clinical trials to extend their own lives, while those with lupus or kidney ...

Last week we distributed a white paper on precision recruitment, a new approach that not only speeds up clinical trial recruitment, but also provides a better patient experience throughout the recruitment process. Now, we're inviting you to join a webinar on March 28th at 12pm, during which we will be diving deeper into this topic.

With medicine getting ever more targeted and precise, clinical trial protocols are becoming more complex than ever before. While this allows for appropriate evaluation of potential treatment options, it also means that finding patients to take part in trials is increasingly challenging, and the need to look beyond traditional methods of recruitment has become clear.

There are conferences we attend to connect with clients. There are conferences we attend to build partnerships. At SCOPE, we are able to do both. The SCOPE Summit convenes the best, the brightest, and the most dedicated in the clinical trial operations space with one aim: to accelerate clinical research. This is why we go to SCOPE.

Once a year, we head to Orlando to collaborate with and learn from some of the best and brightest minds in clinical trial operations. That’s right: we’re attending the SCOPE Summit next week.

It's with great excitement that we share that we have officially partnered with PWNHealth, a virtual care company that enables patient access to diagnostic testing, treatment, and professional guidance, to bolster efficiencies in our clinical trial recruitment by incorporating direct-to-patient lab services.

We’re pleased to share that we have officially partnered with phaware®, an advocacy organization comprised of patients, caregivers, and medical professionals who are dedicated to creating global pulmonary hypertension (PH) awareness, to provide end-to-end patient recruitment services to pharmaceutical companies and CROs running trials in chronic lung diseases.

We know that life with lupus can be difficult at times. And while there's no cure, there is hope: through medical research, we can improve the lives of people living with or affected by lupus — and maybe one day, find a cure.